CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.
Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
大量 NSND 中的 OSCC 显示 PD-L1 表达(CPS 1)。CD4 是 DFS 和 OS 的显著预测因子,此外 CD8/FoxP3 比值是 OS 的近显著预测因子。PD-L1 阳性肿瘤中频繁高 CD8 阳性 TIL 浸润的组合,使 NSND 合并 OSCC 在理论上成为免疫检查点抑制剂治疗的有趣候选者。
确定PD-L1和PD-L2表达以及TIL(肿瘤浸润淋巴细胞)(TILs)在非吸烟者和非饮酒者(NSND)口腔鳞状细胞癌(OSCC)中的存在情况及预后价值。
回顾性收集并分析86例NSND合并OSCC患者的临床特征和肿瘤组织,在组织微阵列上检测蛋白表达。采用免疫组化检测PD-L1 CPS、PD-L2 TPS以及PD-1、CD45、CD8、CD4、CD3和FoxP3阳性TILs/mm²的表达。使用QuPath对切片进行数字化评估。通过log rank分析确定5年DFS和OS的差异。通过多因素cox回归分析确定生存预测因素。
88% (76/86) 的 OSCC 显示 PD-L1 表达 (CPS 1)。CD4 阳性 TIL 数量高的患者比 CD4 阳性 TIL 数量低的患者表现出更好的 DFS 和 OS。在最佳多变量模型中,CD4 阳性 TIL 也是 DFS (p = 0.010) 和 OS (p = 0.002) 的独立预测因子。此外,CD45 阳性 TIL 数量高且 CD8/FoxP3 比值高的患者表现出更好的 OS,其中 CD8/FoxP3 比值是一个接近显著的独立预测因子 (p = 0.050)。超过 40% 的 OSCC 为 PD-L1+/TIL+。
To determine the presence and prognostic value of PD-L1 and PD-L2 expression, and tumor-infiltrating lymphocytes (TILs) in oral squamous cell carcinoma (OSCC) of non-smokers and non-drinkers (NSND).
Clinical characteristics and tumor tissue of 86 NSND with OSCC were retrospectively collected and analyzed for protein expression on tissue microarrays. Immunohistochemistry was performed for expression of PD-L1 CPS, PD-L2 TPS, and PD-1, CD45, CD8, CD4, CD3, and FoxP3-positive TILs/mm 2 . Slides were digitally evaluated using QuPath. Differences in 5-year DFS and OS were determined by log rank analysis. Predictors for survival were determined by multivariable cox regression analysis.
Eighty-eight percent (76/86) of OSCC showed PD-L1 expression (CPS 1). Patients with high numbers of CD4-positive TILs showed a better DFS and OS than patients with low numbers of CD4-positive TILs. In the best multivariable model, CD4-positive TILs were an independent predictor for DFS (p = 0.010) and OS (p = 0.002) too. Additionally, patients with high numbers of CD45-positive TILs and a high CD8/FoxP3 ratio showed a better OS, of which the CD8/FoxP3 ratio was a near significant independent predictor (p = 0.050). Over 40 % of OSCC were PD-L1+/TIL+.
A large number of OSCC in NSND show PD-L1 expression (CPS 1). CD4 was a significant predictor for DFS and OS, in addition to the CD8/FoxP3 ratio being a near significant predictor for OS. The combination of frequent high CD8-positive TIL infiltrates in PD-L1-positive tumors makes NSND with OSCC in theory interesting candidates for treatment with immune checkpoint inhibitors.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。